文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

解析胃癌前病变和早期胃癌的表达谱,探索肠型胃癌发生过程中的关键分子。

Dissecting expression profiles of gastric precancerous lesions and early gastric cancer to explore crucial molecules in intestinal-type gastric cancer tumorigenesis.

机构信息

State Key Laboratory of Molecular Oncology, Department of Etiology and Carcinogenesis, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China.

Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China.

出版信息

J Pathol. 2020 Jun;251(2):135-146. doi: 10.1002/path.5434. Epub 2020 May 27.


DOI:10.1002/path.5434
PMID:32207854
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7317417/
Abstract

Intestinal-type gastric cancer (IGC) has a clear and multistep histological evolution. No studies have comprehensively explored gastric tumorigenesis from inflammation through low-grade intraepithelial neoplasia (LGIN) and high-grade intraepithelial neoplasia (HGIN) to early gastric cancer (EGC). We sought to investigate the characteristics participating in IGC tumorigenesis and identify related prognostic information within the process. RNA expression profiles of 94 gastroscopic biopsies from 47 patients, including gastric precancerous lesions (GPL: LGIN and HGIN), EGC, and paired controls, were detected by Agilent Microarray. During IGC tumorigenesis from LGIN through HGIN to EGC, the number of activity-changed tumor hallmarks increased. LGIN and HGIN had similar expression profiles when compared to EGC. We observed an increase in the stemness of gastric epithelial cells in LGIN, HGIN, and EGC, and we found 27 consistent genes that might contribute to dedifferentiation, including five driver genes. Remarkably, we perceived that the immune microenvironment was more active in EGC than in GPL, especially in the infiltration of lymphocytes and macrophages. We identified a five-gene signature from the gastric tumorigenesis process that could independently predict the overall survival and disease-free survival of GC patients (log-rank test: p < 0.0001), and the robustness was verified in an independent cohort (n > 300) and by comparing with two established prognostic signatures in GC. In conclusion, during IGC tumorigenesis, cancer-like changes occur in LGIN and accumulate in HGIN and EGC. The immune microenvironment is more active in EGC than in LGIN and HGIN. The identified signature from the tumorigenesis process has robust prognostic significance for GC patients. © 2020 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.

摘要

肠型胃癌(IGC)具有明确的多步骤组织学演变过程。目前尚无研究全面探讨从炎症经低级别上皮内瘤变(LGIN)和高级别上皮内瘤变(HGIN)到早期胃癌(EGC)的胃肿瘤发生过程。我们旨在研究参与 IGC 肿瘤发生的特征,并确定该过程中的相关预后信息。通过 Agilent Microarray 检测了 47 名患者的 94 份胃镜活检标本的 RNA 表达谱,包括胃癌前病变(GPL:LGIN 和 HGIN)、EGC 以及配对对照。在 IGC 从 LGIN 经过 HGIN 发展为 EGC 的过程中,发生改变的肿瘤标志数量增加。与 EGC 相比,LGIN 和 HGIN 具有相似的表达谱。我们观察到 LGIN、HGIN 和 EGC 中胃上皮细胞的干性增加,并且发现了 27 个可能有助于去分化的一致基因,其中包括 5 个驱动基因。值得注意的是,我们发现与 GPL 相比,EGC 中的免疫微环境更为活跃,尤其是淋巴细胞和巨噬细胞的浸润。我们从胃肿瘤发生过程中鉴定出一个可以独立预测 GC 患者总生存期和无病生存期的 5 基因签名(对数秩检验:p<0.0001),并在独立队列(n>300)和通过与 GC 中的两个已建立的预后签名进行比较进行了验证。总之,在 IGC 肿瘤发生过程中,LGIN 中出现类似癌症的变化,并在 HGIN 和 EGC 中累积。与 LGIN 和 HGIN 相比,EGC 中的免疫微环境更为活跃。从肿瘤发生过程中鉴定出的签名对 GC 患者具有稳健的预后意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a63f/7317417/0da36f6966d0/PATH-251-135-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a63f/7317417/5c0e06a61448/PATH-251-135-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a63f/7317417/dfeb2f27192c/PATH-251-135-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a63f/7317417/93ea0f706291/PATH-251-135-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a63f/7317417/87ae7043c496/PATH-251-135-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a63f/7317417/106d2d22fe72/PATH-251-135-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a63f/7317417/0da36f6966d0/PATH-251-135-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a63f/7317417/5c0e06a61448/PATH-251-135-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a63f/7317417/dfeb2f27192c/PATH-251-135-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a63f/7317417/93ea0f706291/PATH-251-135-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a63f/7317417/87ae7043c496/PATH-251-135-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a63f/7317417/106d2d22fe72/PATH-251-135-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a63f/7317417/0da36f6966d0/PATH-251-135-g006.jpg

相似文献

[1]
Dissecting expression profiles of gastric precancerous lesions and early gastric cancer to explore crucial molecules in intestinal-type gastric cancer tumorigenesis.

J Pathol. 2020-5-27

[2]
Differential gene expression profiling of gastric intraepithelial neoplasia and early-stage adenocarcinoma.

World J Gastroenterol. 2014-12-21

[3]
Identification of Immune Infiltrating Cell-Related Biomarkers in Early Gastric Cancer Progression.

Technol Cancer Res Treat. 2024

[4]
Expression of Oncostatin M in Early Gastric Cancer and Precancerous Lesions.

Gastroenterol Res Pract. 2019-12-1

[5]
Efficacy of Magnifying Endoscopy with Narrow-Band Imaging in the Diagnosis of Early Gastric Cancer and Gastric Intraepithelial Neoplasia.

Turk J Gastroenterol. 2024-2-16

[6]
Health-Related Quality of Life and Utility Scores of Posttreatment Patients with Gastric Cancer at Different Pathological Stages: A Cross-Sectional Study.

J Oncol. 2022-4-23

[7]
Quantitative Analysis on Molecular Characteristics Evolution of Gastric Cancer Progression and Prognosis.

Adv Biol (Weinh). 2023-10

[8]
Mucosal microbial microenvironment in early gastric neoplasia and non-neoplastic gastric disease.

J Gastroenterol Hepatol. 2021-11

[9]
Molecular evolution of intestinal-type early gastric cancer according to Correa cascade.

J Biomed Res. 2024-9-25

[10]
Disruption of the gastric epithelial barrier in Correa's cascade: Clinical evidence via confocal endomicroscopy.

Helicobacter. 2024

引用本文的文献

[1]
Epidemiology of Helicobacter pylori, gastric precancerous lesions and gastric cancer: a multicenter, population-based cross-sectional study in Nanjing.

BMC Infect Dis. 2025-5-27

[2]
Spatial Study of TLR4, TLR5 and TLR9 in Gastric Premalignant Lesions Before and After Eradication.

Int J Mol Sci. 2025-4-25

[3]
KMO-driven metabolic reconfiguration and its impact on immune cell infiltration in nasopharyngeal carcinoma: a new avenue for immunotherapy.

Cancer Immunol Immunother. 2025-2-1

[4]
Prediction of Patient Drug Response via 3D Bioprinted Gastric Cancer Model Utilized Patient-Derived Tissue Laden Tissue-Specific Bioink.

Adv Sci (Weinh). 2025-3

[5]
Diagnostic and prognostic value of the gasdermins in gastric cancer.

Braz J Med Biol Res. 2024

[6]
Genomic events stratifying prognosis of early gastric cancer.

Gastric Cancer. 2024-11

[7]
Identification of Immune Infiltrating Cell-Related Biomarkers in Early Gastric Cancer Progression.

Technol Cancer Res Treat. 2024

[8]
Exploring the HIF-1α signalling pathway and the mechanism of YiQiHuoXue decoction against Precancerous Lesions of Gastric Cancer based on Network Pharmacology and Molecular Docking.

J Cancer. 2024-5-11

[9]
Serum proteomic profiling of precancerous gastric lesions and early gastric cancer reveals signatures associated with systemic inflammatory response and metaplastic differentiation.

Front Mol Biosci. 2024-3-22

[10]
DNA methylation profiling identifies epigenetic signatures of early gastric cancer.

Virchows Arch. 2024-4

本文引用的文献

[1]
Dissecting the Single-Cell Transcriptome Network Underlying Gastric Premalignant Lesions and Early Gastric Cancer.

Cell Rep. 2019-5-7

[2]
Scoring System for Tumor-Infiltrating Lymphocytes and Its Prognostic Value for Gastric Cancer.

Front Immunol. 2019-1-29

[3]
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

CA Cancer J Clin. 2018-9-12

[4]
Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.

Eur Urol. 2018-8-22

[5]
Dissecting the sources of gene expression variation in a pan-cancer analysis identifies novel regulatory mutations.

Nucleic Acids Res. 2018-5-18

[6]
A Pan-cancer Landscape of Interactions between Solid Tumors and Infiltrating Immune Cell Populations.

Clin Cancer Res. 2018-4-17

[7]
The Immune Landscape of Cancer.

Immunity. 2018-4-5

[8]
Comprehensive Characterization of Cancer Driver Genes and Mutations.

Cell. 2018-4-5

[9]
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation.

Cell. 2018-4-5

[10]
Profiling Tumor Infiltrating Immune Cells with CIBERSORT.

Methods Mol Biol. 2018

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索